INS and metabolic syndrome: Patients with older age at onset,higher level of endogenous insulin and metabolic syndrome were more likely to beable to switch from insulin to other treatments for diabetes [27,28], in two studies on multiethnic groups in USA without comparatorsfrom elsewhere.